{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:30:18Z","timestamp":1787585418070,"version":"build-2736575974"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004740","name":"Fondazione del Monte di Bologna e Ravenna","doi-asserted-by":"publisher","award":["FdM\/4623"],"award-info":[{"award-number":["FdM\/4623"]}],"id":[{"id":"10.13039\/501100004740","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007385","name":"Fondazione Cassa di Risparmio in Bologna","doi-asserted-by":"publisher","award":["2020.0404"],"award-info":[{"award-number":["2020.0404"]}],"id":[{"id":"10.13039\/100007385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.nbd.2026.107516","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:34:21Z","timestamp":1782862461000},"page":"107516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evidence for hippocampal globotriaosylceramide (Gb3) accumulation and spatial memory impairment in a mouse model of Fabry disease"],"prefix":"10.1016","volume":"227","author":[{"given":"Marco","family":"Salluzzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Flotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Delprete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violetta","family":"Lazzarotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Formaggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Vignoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Campolongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Campana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Carboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Canossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Donadio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Caprini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Rimondini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2026.107516_bb0005","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1212\/01.WNL.0000166000.24321.4F","article-title":"Effect of genetic modifiers on cerebral lesions in Fabry disease","volume":"64","author":"Altarescu","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2026.107516_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0079-6123(07)63001-5","article-title":"The dentate gyrus: fundamental neuroanatomical organization (dentate gyrus for dummies)","volume":"163","author":"Amaral","year":"2007","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2026.107516_bb0015","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ajpath.2014.11.004","article-title":"\u03b1-Galactosidase a knockout mice: progressive organ pathology resembles the type 2 later-onset phenotype of fabry disease","volume":"185","author":"Bangari","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2026.107516_bb0020","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ejpain.2011.01.014","article-title":"The relation between small nerve fibre function, age, disease severity and pain in Fabry disease","volume":"15","author":"Biegstraaten","year":"2011","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.nbd.2026.107516_bb0025","doi-asserted-by":"crossref","DOI":"10.1007\/s10545-013-9643-x","article-title":"Cognitive dysfunction and depression in Fabry disease: a systematic review","author":"Bolsover","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.nbd.2026.107516_bb0030","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1136\/jnnp.2008.143693","article-title":"Central nervous system involvement in Anderson-Fabry disease: a clinical and MRI retrospective study","volume":"79","author":"Buechner","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2026.107516_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.813637","article-title":"Role of globotriaosylceramide in physiology and pathology","author":"Celi","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.nbd.2026.107516_bb0040","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4161\/auto.6.5.11943","article-title":"Autophagosome maturation is impaired in Fabry disease","volume":"6","author":"Ch\u00e9vrier","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.nbd.2026.107516_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065246","article-title":"Fabry disease and central nervous system involvement: from big to small, from brain to synapse","author":"Cort\u00e9s-Saladelafont","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.nbd.2026.107516_bb0050","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1212\/WNL.50.6.1746","article-title":"Quantitative analysis of cerebral vasculopathy in patients with Fabry disease","volume":"50","author":"Crutchfield","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2026.107516_bb0055","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2256045","article-title":"Disruption of the microbiota-gut-brain axis is a defining characteristic of the \u03b1-gal a (\u2212\/0) mouse model of Fabry disease","volume":"15","author":"Delprete","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.nbd.2026.107516_bb0060","article-title":"Reduced \u03b1-galactosidase A activity in zebrafish (Danio rerio) mirrors distinct features of Fabry nephropathy phenotype","volume":"31","author":"Elsaid","year":"2022","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.nbd.2026.107516_bb0065","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"Statistics textbooks in the","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.nbd.2026.107516_bb0070","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10545-011-9390-9","article-title":"Hippocampal atrophy as a surrogate of neuronal involvement in Fabry disease","volume":"35","author":"Fellgiebel","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.nbd.2026.107516_bb0075","doi-asserted-by":"crossref","DOI":"10.1177\/17448069221087033","article-title":"L-Acetylcarnitine causes analgesia in mice modeling Fabry disease by up-regulating type-2 metabotropic glutamate receptors","volume":"18","author":"Formaggio","year":"2022","journal-title":"Mol. Pain"},{"key":"10.1016\/j.nbd.2026.107516_bb0080","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac187","article-title":"Structural disconnection and functional reorganization in Fabry disease: a multimodal MRI study","volume":"4","author":"Gabusi","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.nbd.2026.107516_bb0085","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/j.pain.0000000000003818","article-title":"The prokineticin system and glia cells as pharmacological targets to control neuroinflammation and to relieve pain in a murine model of Fabry-Anderson disease","volume":"167","author":"Galimberti","year":"2026","journal-title":"Pain"},{"key":"10.1016\/j.nbd.2026.107516_bb0090","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","author":"Germain","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.nbd.2026.107516_bb0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00868342","article-title":"Stroke in Fabry\u2019s disease","volume":"241","author":"Grewal","year":"1994","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2026.107516_bb0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5414\/NP300817","article-title":"ERG is a novel and reliable marker for endothelial cells in central nervous system tumors","volume":"34","author":"Haber","year":"2015","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.nbd.2026.107516_bb0105","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s00415-004-0364-9","article-title":"Reduced cerebral blood flow velocity and impaired cerebral autoregulation in patients with Fabry disease","volume":"251","author":"Hilz","year":"2004","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2026.107516_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180601","article-title":"Affective and cognitive behavior in the alpha-galactosidase A deficient mouse model of Fabry disease","volume":"12","author":"Hofmann","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2026.107516_bb0115","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1006\/bbrc.1996.1112","article-title":"A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage 1","volume":"224","author":"Imai","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2026.107516_bb0120","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1074\/jbc.RA120.012665","article-title":"Determination of globotriaosylceramide analogs in the organs of a mouse model of Fabry disease","volume":"295","author":"Ishii","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2026.107516_bb0125","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1046\/j.1471-4159.2001.00669.x","article-title":"Local and global cerebral blood flow and glucose utilization in the \u03b1-galactosidase a knockout mouse model of Fabry disease","volume":"79","author":"Itoh","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2026.107516_bb0130","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1194\/jlr.RA120000909","article-title":"Assessing the role of glycosphingolipids in the phenotype severity of Fabry disease mouse model","volume":"61","author":"Jabbarzadeh-Tabrizi","year":"2020","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.nbd.2026.107516_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0325403","article-title":"The insidious degeneration of white matter and cognitive decline in Fabry disease","volume":"20","author":"Johnson","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2026.107516_bb0140","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.gene.2017.10.064","article-title":"Female Fabry disease patients and X-chromosome inactivation","volume":"641","author":"Juchniewicz","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.nbd.2026.107516_bb0145","first-page":"505","article-title":"Nervous system involvement in Fabry\u2019s disease: clinicopathological and biochemical correlation","volume":"23","author":"Kaye","year":"1988"},{"key":"10.1016\/j.nbd.2026.107516_bb0150","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fnmol.2018.00201","article-title":"Altered gene expression in prefrontal cortex of a fabry disease mouse model","volume":"11","author":"Kummer","year":"2018","journal-title":"Front Mol. Neurosci."},{"key":"10.1016\/j.nbd.2026.107516_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.106797","article-title":"Anxiety-like behavior and altered hippocampal activity in a transgenic mouse model of Fabry disease","volume":"205","author":"Kummer","year":"2025","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2026.107516_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108641","article-title":"Pain related channels are differentially expressed in neuronal and non-neuronal cells of glabrous skin of fabry knockout male mice","volume":"9","author":"Lakom\u00e1","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2026.107516_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1744806916663729","article-title":"Increased expression of trpv1 in peripheral terminals mediates thermal nociception in fabry disease mouse model","volume":"12","author":"Lakom\u00e1","year":"2016","journal-title":"Mol. Pain"},{"key":"10.1016\/j.nbd.2026.107516_bb0170","doi-asserted-by":"crossref","DOI":"10.1007\/s10545-009-9025-6","article-title":"Social-adaptive and psychological functioning of patients affected by Fabry disease","volume":"33","author":"Laney","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.nbd.2026.107516_bb0180","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.2214\/AJR.05.0019","article-title":"Imaging features of Fabry disease","volume":"186","author":"Lidove","year":"2006","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.nbd.2026.107516_bb0185","series-title":"JIMD Reports","first-page":"73","article-title":"Cognitive Impairments and Subjective Cognitive Complaints in Fabry Disease: A Nationwide Study and Review of the Literature","author":"Loeb","year":"2018"},{"key":"10.1016\/j.nbd.2026.107516_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.12833","article-title":"Unifying biology of neurodegeneration in lysosomal storage diseases","volume":"48","author":"Ludlaim","year":"2025","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.nbd.2026.107516_bb0195","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13529","article-title":"Altered globotriaosylceramide accumulation and mucosal neuronal fiber density in the colon of the Fabry disease mouse model","volume":"31","author":"Masotti","year":"2019","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.nbd.2026.107516_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2015.12.362","article-title":"The \u03b1-galactosidase A-deficient rat: characterization of a new animal model of Fabry disease","volume":"117","author":"Miller","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.nbd.2026.107516_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2019.129437","article-title":"Progress in the understanding and treatment of Fabry disease","author":"Miller","year":"2020","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.nbd.2026.107516_bb0210","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ana.410400105","article-title":"Cerebrovascular complications of Fabry\u2019s disease","volume":"40","author":"Mitsias","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2026.107516_bb0215","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1161\/hs0202.102601","article-title":"Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement","volume":"33","author":"Moore","year":"2002","journal-title":"Stroke"},{"issue":"1\u20132","key":"10.1016\/j.nbd.2026.107516_bb0220","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jns.2007.01.053","article-title":"The cerebral vasculopathy of Fabry disease","volume":"257","author":"Moore","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2026.107516_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.829128","article-title":"Neuropsychiatric symptoms and their association with sex, age, and enzyme replacement therapy in Fabry disease: a systematic review","author":"Mroczek","year":"2022","journal-title":"Front. Psychiatry"},{"issue":"3","key":"10.1016\/j.nbd.2026.107516_bb0230","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/archneur.63.3.453","article-title":"Later-onset Fabry disease: an adult variant presenting with the cramp-fasciculation syndrome","volume":"63","author":"Nance","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2026.107516_bb0235","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1093\/hmg\/ddad073","article-title":"Elucidating the toxic effect and disease mechanisms associated with Lyso-Gb3 in Fabry disease","volume":"32","author":"Nikolaenko","year":"2023","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2026.107516_bb0240","series-title":"Advances in Applied Microbiology","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2164(10)71001-7","article-title":"Influence of Escherichia coli Shiga toxin on the mammalian central nervous system","author":"Obata","year":"2010"},{"key":"10.1016\/j.nbd.2026.107516_bb0245","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.3390\/toxins2081997","article-title":"Distribution of Gb 3 immunoreactivity in the mouse central nervous system","volume":"2","author":"Obata","year":"2010","journal-title":"Toxins (Basel)."},{"key":"10.1016\/j.nbd.2026.107516_bb0250","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-024-03624-9","article-title":"Rapidly progressive cognitive impairment resulting in heavy psychosocial burden in a patient with Fabry disease undergoing hemodialysis: a case report","volume":"25","author":"Ohsawa","year":"2024","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.nbd.2026.107516_bb0255","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.94.6.2540","article-title":"\u03b1-Galactosidase A deficient mice: a model of fabry disease","volume":"94","author":"Ohshima","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2026.107516_bb0260","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1440-1789.2008.00883.x","article-title":"An autopsy case of Fabry disease with neuropathological investigation of the pathogenesis of associated dementia","volume":"28","author":"Okeda","year":"2008","journal-title":"Neuropathology"},{"key":"10.1016\/j.nbd.2026.107516_bb0265","doi-asserted-by":"crossref","DOI":"10.1007\/s00059-002-2429-9","article-title":"Fabry disease: focus on cardiac manifestations and molecular mechanisms","author":"Perrot","year":"2002","journal-title":"Herz"},{"key":"10.1016\/j.nbd.2026.107516_bb0270","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00234-024-03380-5","article-title":"In vivo demonstration of globotriaosylceramide brain accumulation in Fabry disease using MR relaxometry","volume":"66","author":"Pontillo","year":"2024","journal-title":"Neuroradiology"},{"key":"10.1016\/j.nbd.2026.107516_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2025.109110","article-title":"The use and performance of lyso-Gb3 for the diagnosis and monitoring of Fabry disease: a systematic literature review","author":"Ramaswami","year":"2025","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.nbd.2026.107516_bb0285","doi-asserted-by":"crossref","DOI":"10.1007\/s11940-016-0414-5","article-title":"Fabry disease: recognition, diagnosis, and treatment of neurological features","author":"Ranieri","year":"2016","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.nbd.2026.107516_bb0290","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.brainresbull.2021.07.027","article-title":"Nociceptive behavior and central neuropeptidergic dysregulations in male and female mice of a Fabry disease animal model","volume":"175","author":"Rullo","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2026.107516_bb0295","doi-asserted-by":"crossref","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.nbd.2026.107516_bb0300","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/arclin\/acu047","article-title":"Cognitive and psychological functioning in Fabry disease","volume":"29","author":"Sigmundsdottir","year":"2014","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.nbd.2026.107516_bb0305","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neuroscience.2016.07.031","article-title":"Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of down syndrome","volume":"333","author":"Stagni","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2026.107516_bb0310","doi-asserted-by":"crossref","DOI":"10.3791\/56188","article-title":"Simple elimination of background fluorescence in formalin-fixed human brain tissue for immunofluorescence microscopy","author":"Sun","year":"2017","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.nbd.2026.107516_bb0315","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/BJ20130825","article-title":"A symptomatic Fabry disease mouse model generated by inducing globotriaosylceramide synthesis","volume":"456","author":"Taguchi","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2026.107516_bb0320","article-title":"Distinctive accumulation of globotriaosylceramide and globotriaosylsphingosine in a mouse model of classic Fabry disease","volume":"34","author":"Taguchi","year":"2023","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.nbd.2026.107516_bb0325","article-title":"Molecular pathogenesis of central and peripheral nervous system complications in Anderson\u2013Fabry disease","author":"Tuttolomondo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2026.107516_bb0330","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1093\/brain\/awaa282","article-title":"White matter integrity correlates with cognition and disease severity in Fabry disease","volume":"143","author":"Ulivi","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2026.107516_bb0335","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nprot.2006.116","article-title":"Morris water maze: procedures for assessing spatial and related forms of learning and memory","volume":"1","author":"Vorhees","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.nbd.2026.107516_bb0340","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/0002-9343(65)90086-0","article-title":"Angiokeratoma corporis diffusum universale (Fabry)","volume":"39","author":"Wallace","year":"1965","journal-title":"Am. J. Med."},{"key":"10.1016\/j.nbd.2026.107516_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/cells13131131","article-title":"Expanding the neurological phenotype of Anderson\u2013Fabry disease: proof of concept for an extrapyramidal neurodegenerative pattern and comparison with monogenic vascular Parkinsonism","author":"Zedde","year":"2024","journal-title":"Cells"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126002615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126002615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:51:58Z","timestamp":1787583118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996126002615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":67,"alternative-id":["S0969996126002615"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107516","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence for hippocampal globotriaosylceramide (Gb3) accumulation and spatial memory impairment in a mouse model of Fabry disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107516","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107516"}}